Governance by a Management Board made up of Key Opinion Leaders from the following disease groups:
- Movement Disorders
- Multiple Sclerosis
- Mental Health
- Neuromuscular Diseases
Our General Manager
Dr Tina Soulis
Tina drives the clinical development of projects for academic and commercial sponsors. When planning your clinical trial, you can be assured it will be overseen by one of Australia’s most experienced operators in the field.
Prior to her role with Neuroscience Trials Australia, Tina was the director of clinical development at Acrux Pharma Pty Ltd, a successful Australian biotechnology company. She managed the strategic direction, development, co-ordination and reporting of the company’s clinical programs. Tina had pivotal involvement in taking a product (Axiron), right through all stages of clinical development and in submission of the product dossier for regulatory approval.
Tina is an experienced driver of clinical drug development, particularly in the design, management and implementation of clinical trials and has worked as a clinical researcher and in senior roles within the pharmaceutical and biotechnology industry for over 20 years. Her experience encompasses all stages of drug development in many therapeutic areas and geographical regions.
Tina has held senior clinical positions with Kendle (now INC Research, a global CRO) that involved the leadership of projects and personnel for numerous biotechnology and pharma clients. Prior to Kendle, Tina was a post doctoral research manager responsible for a team of scientists developing new drugs for the management of diabetic disease.
Professor Stephen Davis MB BS, MD, FRACP, FRCP (Edin)
Stephen Davis is Professor of Neurology, University of Melbourne, Divisional Director of Neurosciences, Director of Neurology and Head of the Stroke Service at Royal Melbourne Hospital. He is the current President of the World Stroke Congress and is Past President of the Stroke Society of Australasia as well as past Chairman of the Education Committee for the World Congress of Neurology 2005.
From 2002 to 2005 Professor Davis chaired the Royal Melbourne Hospital Human Research Ethics Committee. He is an Honorary Principal Fellow of the Howard Florey Institute.
He has published over 200 papers, 21 book chapters, and co-authored 2 texts, ‘Interventional Stroke Therapy’ and ‘Magnetic Resonance Imaging in Stroke.’ He has chaired or served on numerous national and international committees. He has extensive experience in cerebrovascular research, with interests in acute interventional therapies, new magnetic resonance imaging techniques in brain ischaemia, as well as secondary prevention and brain recovery.
He is a member of six editorial boards including Stroke, Cerebrovascular Disease, Journal of Neuroimaging and Journal of Clinical Neuroscience. He has served on numerous national and international steering committees for acute stroke and secondary prevention trials.
Professor Geoffrey Donnan, MB BS, MD, FRACP, FRCP(Edin)
Geoffrey A. Donnan, MD is Director of the Florey Institute of Neuroscience and Mental Health and Professor of Neurology, University of Melbourne, Austin Hospital in Australia.
He was co-founder with Professor Stephen Davis of the Australian Stroke Trials Network (ASTN) within which there have been conducted numerous investigator driven and other stroke trials. He is Past President of the Stroke Society of Australasia and Past President of the Australian Association of Neurologists.
Professor Donnan has been involved in a number of international initiatives, including establishment of the World Neurology Foundation and the World Stroke Foundation (Secretary). He has chaired the scientific committee or executive committees of a number of international meetings including the 6th International Symposium on Thrombolysis and Acute Stroke (2000), World Stroke Congress (2000) and World Congress of Neurology (2005) and was co-chair of the Education Committee for the World Stroke Congress, Vienna 2008.
Professor Donnan has published over 400 papers in peer reviewed journals, over 60 book chapters, edited 4 books and has been Lecturer or Visiting Professor in numerous countries. He has trained a large number of Fellows in stroke neurology who now work throughout Australia and other parts of the world. He has served on many international journal editorial boards including Stroke (Co-Section Editor for Stroke Controversies), Cerebrovascular Diseases (Associate Editor) Lancet Neurology and is currently Editor in Chief of the International Journal of Stroke.